Intermittent Parathyroid Hormone after Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats

Postmenopausal osteoporosis is often treated with bisphosphonates (e.g. alendronate, ALN), but over-suppression of bone turnover by long-term bisphosphonate treatment may decrease bone tissue heterogeneity. Thus, alternate treatment strategies after long-term bisphosphonates are of great clinical in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Bone Miner Res
Egile Nagusiak: Altman-Singles, Allison R., Jeong, Yonghoon, Tseng, Wei-Ju, de Bakker, Chantal M. J., Zhao, Hongbo, Lott, Carina, Robberts, Juhanna, Qin, Ling, Han, Lin, Kim, Do-Gyoon, Liu, X. Sherry
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550334/
https://ncbi.nlm.nih.gov/pubmed/28467646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.3165
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak